T116 Trademark

Trademark Overview

On Thursday, April 16, 2020, a trademark application was filed for T116 with the United States Patent and Trademark Office. The USPTO has given the T116 trademark a serial number of 88874188. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 6, 2023. This trademark is owned by TAIHO PHARMACEUTICAL CO., LTD.. The T116 trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; tumor suppressing agents; chemical reagents for medical purposes in the field of oncology
t116

General Information

Serial Number88874188
Word MarkT116
Filing DateThursday, April 16, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 6, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 11, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; tumor suppressing agents; chemical reagents for medical purposes in the field of oncology
Pseudo MarkT 116; T 1 1 6; T ONE HUNDRED SIXTEEN

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 24, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTAIHO PHARMACEUTICAL CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 101-8444
JP
Party NameTAIHO PHARMACEUTICAL CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 101-8444
JP

Trademark Events

Event DateEvent Description
Monday, November 6, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 6, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, April 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 6, 2023SOU EXTENSION 5 GRANTED
Tuesday, March 28, 2023SOU EXTENSION 5 FILED
Wednesday, April 5, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 28, 2023SOU TEAS EXTENSION RECEIVED
Saturday, October 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 29, 2022SOU EXTENSION 4 GRANTED
Thursday, September 29, 2022SOU EXTENSION 4 FILED
Thursday, September 29, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, March 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 28, 2022SOU EXTENSION 3 GRANTED
Monday, March 28, 2022SOU EXTENSION 3 FILED
Monday, March 28, 2022SOU TEAS EXTENSION RECEIVED
Friday, September 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 22, 2021SOU EXTENSION 2 GRANTED
Wednesday, September 22, 2021SOU EXTENSION 2 FILED
Wednesday, September 22, 2021SOU TEAS EXTENSION RECEIVED
Thursday, March 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 23, 2021SOU EXTENSION 1 GRANTED
Tuesday, March 23, 2021SOU EXTENSION 1 FILED
Tuesday, March 23, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, October 6, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 11, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 11, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 22, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 9, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 8, 2020ASSIGNED TO EXAMINER
Friday, April 24, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 20, 2020NEW APPLICATION ENTERED

Related Keywords

preparations pharmaceutical tumor cancer treatment purposes field medical oncology suppressing